27 November 2018
Urinary incontinence and pelvic organ prolapse are the most common pelvic floor disorders that affect 24-46% of women world-wide. These common multifactorial conditions are poorly understood, understudied and have suboptimal treatments. With this grant the research group will investigate genetic and biological processes involved in the development pelvic floor disorders and select possible repurposed drugs in the treatment of these conditions.
An EFRO grant (European Fund for Regional Development) of € 948,808 was assigned to the researchgroup of the DIABIP project led by Kirsten Kluivers, urogynaecologist of the Radboudumc, and part of the theme Reconstructive and regenerative medicine.
DIABIP, diagnosis and treatment for urinary incontinence and pelvic organ prolapse, is a research collaboration project between the gynaecology (Kirsten Kluivers, Alejandra Ruiz-Zapata and Wilke Post), urology (John Heesakkers, Egbert Oosterwijk and Dick Janssen) and genetics department (Geert Poelmans and Marieke Coenen) of the Radboudumc and the two SME's DrugtargetID and Nimagen.Urinary incontinence and pelvic organ prolapse are the most common pelvic floor disorders that affect 24-46% of women world-wide. These common multifactorial conditions are poorly understood, understudied and have suboptimal treatments. With this grant the research group will investigate genetic and biological processes involved in the development pelvic floor disorders and select possible repurposed drugs in the treatment of these conditions.
-
Want to know more about these subjects? Click on the buttons below for more news.